Ricky Turgeon BSc(Pharm), ACPR, PharmD
Collaboration for Outcomes Research and Evaluation (CORE)
Scientist, Centre for Health Evaluation & Outcome Sciences (CHÉOS)
Clinical Pharmacy Specialist, PHARM-HF Clinic, St. Paul’s Hospital
Researcher, Centre for Cardiovascular Innovation
Dr. Ricky Turgeon received his BSc(Pharm) in 2012 from the Dalhousie University College of Pharmacy, his ACPR from the Lower Mainland Pharmacy Services Residency Program in 2013, and his PharmD in the Faculty of Pharmaceutical Sciences at UBC in 2015. He then completed a two-year post-doctoral fellowship with Drs. Glen Pearson and Sheri Koshman at the University of Alberta Faculty of Medicine & Dentistry (Division of Cardiology) in 2018. Currently, Dr. Turgeon is assistant professor at the UBC Faculty of Pharmaceutical Sciences, and clinical pharmacy specialist at the PHARM-HF clinic, a pharmacist-led heart failure medication optimization clinic, at St. Paul's Hospital in Vancouver.
Dr. Turgeon’s research focuses on integrating evidence and shared decision-making into the care of people living with cardiovascular disease, and evaluating these using several observational and experimental methodologies. His clinical interests are in heart failure pharmacotherapy, cardiovascular safety of medications, and in therapies to reduce cardiovascular risk factors, including antithrombotic, lipid-lowering, antihypertensive, and antihyperglycemic medications.
Turgeon RD, Koshman SL, Dong Y, Graham MM. P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications. Eur Heart J 2022;43:2303-13. Available at: https://doi.org/10.1093/eurheartj/ehac116 [PMID: 35296876]
MacDonald BJ, Barry AR, Turgeon RD. Decisional Needs and Patient Treatment Preferences for Heart Failure Medications: Scoping Review. Can J Cardiol Open 2022; https://doi.org/10.1016/j.cjco.2022.11.013. Available at: https://www.cjcopen.ca/article/S2589-790X(22)00250-5/fulltext
Barry AR, Kosar L, Koshman SL, Turgeon RD. Medication management for heart failure with reduced ejection fraction: Clinical pearls for optimizing evidenced-informed therapy. Canadian Family Physician 2021;67(12):915-22. Available at: https://www.cfp.ca/content/cfp/67/12/915.full.pdf [PMID: 34906941]
Turgeon RD, Althouse AD, Cohen JB, Enache B, Hogenesch JB, Johansen ME, Mehta R, Meyerowitz-Katz G, Ziaeian B, Hiremath S. Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: Controversies in hypertension – con side of the argument. Hypertension 2021;78:871-8.
Turgeon RD, Barry AR, Hawkins NH, Ellis UM. Pharmacotherapy for Heart Failure with Reduced Ejection Fraction and Health-Related Quality of Life: Systematic Review and Meta-Analysis. Eur J Heart Fail 2021;23(4):578-89. [PMID: 33634543]
Cao VFS, Cowley E, Koshman SL, MacGillivray J, Sidsworth M, Turgeon RD. Pharmacist-led optimization of heart failure medications: A systematic review. J Am Coll Clin Pharm 2021;4:862-70.
Andrade JG, Wazni OM, Kuniss M, Hawkins NM, Deyell MW, Chierchia GB, Nissen S, Verma A, Wells GA, Turgeon RD. Cryoballoon ablation as initial treatment for atrial fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:914-30. Available at: https://www.jacc.org/doi/pdf/10.1016/j.jacc.2021.06.038
Wong E, Fordyce CB, Wong G, Lee T, Perry Arnesen M, Mackay M, Singer J, Cairns J, Tocher W, Turgeon RD. Predictors of the use of mineralocorticoid receptor antagonists in patients with left ventricular dysfunction post-ST-segment-elevation myocardial infarction. J Am Heart Assoc 2021;0:e019167. Available online at: https://www.ahajournals.org/doi/full/10.1161/JAHA.120.019167
Turgeon RD, Koshman SL, Youngson E, Har B, Wilton SB, James MT, Graham MM. Association of ticagrelor vs clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA Internal Medicine 2020;80(3):420-8. [PMID: 31930361]
Turgeon RD, Kolber MR, Loewen P, Ellis U, McCormack JP. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis. PLoS ONE 2019;14(2):e0212907. Available at: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.02129… [PMID: 30817783]
"Best Clinical Science Award." Turgeon RD. University of Alberta, Faculty of Medicine and Dentistry – Mazankowski Alberta Heart Institute 2018 Cardiac Sciences Research Day. June 2018.
“Resident Impact Award.” Turgeon RD. Lower Mainland Pharmacy Services Pharmacy Practice Residency Program. June 2013.
“Patient Treatment Preferences and Decisional Needs for Heart Failure Medications” Turgeon RD (PI). $100,000. CIHR Project Grant – Priority Announcement: Patient-Oriented Research (Early-Career Investigator). 2022-2023.
“Pharmacist-led intervention for Optimal Heart Failure Medications: A pilot randomized controlled trial (PHARM Optimal-HF Pilot).” Turgeon RD (PI). $48,587.50. Canadian Foundation for Pharmacy Innovation Fund Grant. 2022-2024.
“Canadian Heart Function Alliance”. CIHR Heart Failure Research Network Team Grant. Co-I. $5,000,000. CIHR Heart Failure Research Network Team Grant. 2022-2027.
“Repository and Development of Point-of-Care Decision Support Tools for Family Physicians.” Korownyk T (PI), Turgeon R, Kolber M, McCOrmack J, Falk J, Ton J. University of Alberta (Northern Alberta Academic Family Medicine Fund). 2022-2023.
Heart Failure Medications Demystified: A Simplified, Patient-Centered Approach. Family Medicine Forum (FMF). Virtual; November 18, 2022.
CCPN Spotlight: Practical Approach to DOACs: A Dozen Years of Use, a Dozen Questions Remaining. Canadian Cardiovascular Congress 2022. Ottawa, ON; October 27, 2022.
The Heart of What Matters: Cardiology Update 2022. Practical Evidence for Informed Practice (PEIP) Conference 2022. Edmonton, AB; October 22, 2022.
Effects of Non-Cardiovascular Drugs on the Heart. Heart Failure Update 2021. Canadian Heart Failure Society. Virtual; May 8, 2021.
How to Critically Appraise a Trial in 10 Minutes. Professional Practice Conference 2020. Toronto, ON; February 3, 2020.
Centre for Health Evaluation & Outcome Sciences (CHEOS). Discover PHARM-HF, a clinic connecting pharmacists with patients with heart failure. November 24, 2021. Available at: https://cheos.ubc.ca/research-in-action/discover-pharm-hf-a-clinic-conn…
Interview. Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists. TCTMD. 2021 July 9. Available at: https://www.tctmd.com/news/studies-explore-post-mi-use-beta-blockers-mi…
Interview. Should journals credit eagle-eyed readers by name in retraction notices? Retraction Watch. 2019 February 6. Available at: https://retractionwatch.com/2019/02/06/should-journals-credit-eagle-eye…
Office 5523, Pharmaceutical Sciences Building